SCHEMBL3492708

SCHEMBL3492708

C=C1C[C@]23CC[C@H]4C(C)(C)C(=O)CC[C@]4(C)[C@H]2CC[C@@H]1C3

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 5/20 0.58
▸ HSD11B1 P28845 3/20 0.57
▸ HSD11B2 P80365 1/20 0.57
▸ GP6 Q9HCN6 1/20 0.42
▸ IL1B P01584 1/20 0.40
▸ LMNA P02545 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ PTPRF P10586 1/20 0.39
▸ ACP1 P24666 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CES2 O00748 2/20 0.38
▸ CES1 P23141 1/20 0.38
▸ BCHE P06276 2/20 0.38
▸ ACHE P22303 2/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ NT5E P21589 1/20 0.37
▸ GPBAR1 Q8TDU6 1/20 0.37
▸ PTPN2 P17706 2/20 0.36
▸ F3 P13726 1/20 0.35
▸ PNLIP P16233 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13401510 1.00 PTPN1 (0.58) PTPN1HSD11B1HSD11B2GP6IL1B
SCHEMBL3492706 1.00 PTPN1 (0.58) PTPN1HSD11B1HSD11B2GP6IL1B
SCHEMBL13401523 0.77 PTPN1 (0.56) PTPN1HSD11B1HSD11B2BCHEACHE
Phyllocladene SCHEMBL156928 0.77 HSD11B1 (0.72) PTPN1HSD11B1HSD11B2BCHEACHE
Phyllocladene SCHEMBL1006869 0.77 HSD11B1 (0.72) PTPN1HSD11B1HSD11B2BCHEACHE
Phyllocladene SCHEMBL29388334 0.77 HSD11B1 (0.72) PTPN1HSD11B1HSD11B2BCHEACHE
Phyllocladene SCHEMBL1006868 0.77 HSD11B1 (0.72) PTPN1HSD11B1HSD11B2BCHEACHE
Phyllocladene SCHEMBL29437839 0.77 HSD11B1 (0.72) PTPN1HSD11B1HSD11B2BCHEACHE
SCHEMBL267552 0.74 PTPN1 (0.65) PTPN1HSD11B1HSD11B2BCHEACHE
SCHEMBL29546419 0.74 PTPN1 (0.65) PTPN1HSD11B1HSD11B2BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100099640-A1 TISSUE DEGENERATION PROTECTION GEUNS JOANNES 2010-04-22 — — US disclosed
EP-2155769-A2 TISSUE DEGENERATION PROTECTION Katholieke Universiteit Leuven (BE) 2010-02-24 — — EP disclosed
WO-2008134828-A2 TISSUE DEGENERATION PROTECTION KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2008-11-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099640-A1 TISSUE DEGENERATION PROTECTION SORD, CASP3, TXNRD2 PTPN1 3492/4885HSD11B1 187/4885HSD11B2 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback